What it does
Hidrosmin is a medication that helps improve blood flow and reduce swelling in the legs.
Commonly used for: chronic venous insufficiency, varicose veins, swelling in the legs
Read more in plain English ↓Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.
Ask about this medicine
Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.
Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.
Sourcing - Kenya onlyRegistration & product details
Source: Zambia Medicines Regulatory Authority · fetched 2026-03-12 00:07:19 · updated 2026-09-17 03:34:48
About this medicine
Hidrosmin is a medication that helps improve blood flow and reduce swelling in the legs.
What it treats
- chronic venous insufficiency
- varicose veins
- swelling in the legs
How it works
Hidrosmin works by strengthening the blood vessels and improving circulation, which helps to relieve discomfort and swelling.
Who it's for
It is suitable for adults who experience symptoms related to poor blood flow in the legs.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
Clinical monograph: hidrosmin
BNF-referencedHidrosmin is a flavonoid compound, primarily derived from the Dioscorea species, known for its venotonic properties. It is utilized in the treatment of chronic venous insufficiency, hemorrhoids, and other vascular disorders due to its ability to improve venous tone and reduce capillary permeability.
Indications
- Chronic venous insufficiency
- Hemorrhoids
- Varicose veins
- Lymphedema
Dosage
Children: Paediatric dosing information for hidrosmin is not readily available; therefore, it is recommended to consult the BNF for Children or a healthcare professional for appropriate dosing in children.
Adults: For adults, the typical dosage of hidrosmin is 500 mg to 1000 mg taken orally, usually divided into two or three doses per day. It is advisable to refer to specific guidelines or the BNF for further details regarding dosing adjustments based on individual patient needs.
Mechanism of action
Hidrosmin exerts a venotonic effect by enhancing venous tone, which is mediated through a combination of increased venous return and reduced venous distensibility. This is thought to be due to its action on the vascular smooth muscle, promoting contraction and thereby improving venous drainage. Additionally, it may decrease capillary permeability and inhibit inflammatory mediators, contributing to its effectiveness in venous disorders.
Pharmacodynamics
Pharmacodynamically, hidrosmin improves microcirculation and reduces venous stasis, which can alleviate symptoms associated with venous insufficiency such as pain, swelling, and heaviness in the legs. Its anti-inflammatory properties may also play a role in reducing discomfort associated with hemorrhoids and other inflammatory vascular conditions.
Pharmacokinetics
Hidrosmin is well absorbed after oral administration, with peak plasma concentrations typically occurring within 1-2 hours. It undergoes extensive hepatic metabolism, resulting in several metabolites that may also contribute to its therapeutic effects. The elimination half-life is approximately 4-6 hours, and it is primarily excreted through the urine.
Pregnancy
There is limited data on the use of hidrosmin during pregnancy. It should only be used if the potential benefit justifies the potential risk to the fetus.
Breast-feeding
There is insufficient information on the excretion of hidrosmin in human milk. Caution should be exercised when administering to breastfeeding women.
Storage
Store in a cool, dry place away from direct sunlight. Keep out of reach of children.
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.
Molecular reference: hidrosmin
PubChem CID 3087722Molecular formula: C30H36O16
Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.
This drug in other countries
The same active ingredient registered across other registries we cover - including different brands.